Evidence map›Paper›PMID 41038817›Full record

ArticleNature communications2025

Identification of a RAB32-LRMDA-Commander membrane trafficking complex reveals the molecular mechanism of human oculocutaneous albinism type 7.

Rebeka Butkovič, Michael D Healy, Cecilia de Heus, Alexander P Walker, Wyatt Beyers, Kerrie E McNally, Philip A Lewis, Kate J Heesom, Nalan Liv, Judith Klumperman and 3 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Structural Mechanisms of DNAJC13 Dimeric Assembly and InsPbioRxiv : the preprint server for biology · 2026
    Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Rebeka ButkovičSchool of Biochemistry, Faculty of Life Sciences, Biomedical Sciences Building, University of Bristol, Bristol, BS8 1TD, UK. rebeka.butkovic@bristol.ac.uk.ORCID http://orcid.org/0000-0002-6911-1265
Michael D HealyCentre for Cell Biology of Chronic Disease, Institute for Molecular Biosciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.ORCID http://orcid.org/0000-0003-2924-9179
Cecilia de HeusCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, 3584 CX, Utrecht, The Netherlands.
Alexander P WalkerSchool of Biochemistry, Faculty of Life Sciences, Biomedical Sciences Building, University of Bristol, Bristol, BS8 1TD, UK.
Wyatt BeyersDepartment of Biochemistry and Molecular Biology, Colorado State University, 111 MRC Building, 1870 Campus Delivery, Fort Collins, Colorado, 80523-1870, USA.ORCID http://orcid.org/0000-0001-9095-2715
Kerrie E McNallyMRC Laboratory of Molecular Biology, Cambridge, UK.ORCID http://orcid.org/0000-0003-2376-3003
Philip A LewisBristol Proteomics Facility, School of Biochemistry, Faculty of Life Sciences, Biomedical Sciences Building, University of Bristol, Bristol, BS8 1TD, UK.ORCID http://orcid.org/0000-0002-2868-2459
Kate J HeesomBristol Proteomics Facility, School of Biochemistry, Faculty of Life Sciences, Biomedical Sciences Building, University of Bristol, Bristol, BS8 1TD, UK.ORCID http://orcid.org/0000-0002-5418-5392
Nalan LivCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, 3584 CX, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-2654-9117
Judith KlumpermanCenter for Molecular Medicine, University Medical Center Utrecht, Utrecht University, 3584 CX, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0003-4835-6228
Santiago Di PietroDepartment of Biochemistry and Molecular Biology, Colorado State University, 111 MRC Building, 1870 Campus Delivery, Fort Collins, Colorado, 80523-1870, USA.ORCID http://orcid.org/0000-0002-3372-8757
Brett M CollinsCentre for Cell Biology of Chronic Disease, Institute for Molecular Biosciences, The University of Queensland, St. Lucia, QLD, 4072, Australia.ORCID http://orcid.org/0000-0002-6070-3774
Peter J CullenSchool of Biochemistry, Faculty of Life Sciences, Biomedical Sciences Building, University of Bristol, Bristol, BS8 1TD, UK. pete.cullen@bristol.ac.uk.ORCID http://orcid.org/0000-0002-9070-8349

Funding

Molecular Mechanisms of Platelet Alpha Granule BiogenesisR01HL151988 · NHLBI · COLORADO STATE UNIVERSITY · PI DI PIETRO, SANTIAGO MAURO · 2021 to 2024
$1.5M
NHLBI NIH HHS R01 HL151988RCUK | Medical Research Council (MRC) MR/L007363/1RCUK | Medical Research Council (MRC) MR/P018807/1Royal Society RSRP/R1/211004Wellcome TrustWellcome Trust (Wellcome) 104568/Z/14/ZWellcome Trust (Wellcome) 220260/Z/20/ZWellcome Trust (Wellcome) 220480/Z/20/Z
6 · The paper itself

Abstract

The endosomal Commander assembly associates with the sorting nexin-17 (SNX17) cargo adaptor to regulate cell surface recycling of internalised integral proteins including integrins and lipoprotein receptors. Here, we identify leucine rich melanocyte differentiation associated (LRMDA) as a Commander binding protein. We reveal that LRMDA and SNX17 share a common mechanism of Commander association, and that LRMDA simultaneously associates with Commander and active RAB32, establishing distinct RAB32-LRMDA-Commander and SNX17-Commander assemblies. Functional analysis in melanocytes reveals distinct roles for RAB32-LRMDA-Commander and SNX17-Commander in melanosome biogenesis. We reveal how LRMDA mutations, causative for oculocutaneous albinism type 7, a hypopigmentation disorder accompanied by poor visual acuity, uncouple RAB32 and Commander binding thereby establishing the mechanistic basis of this disease. Our discovery of this alternative Commander assembly highlights the plasticity of Commander function in human pigmentation and extends the Commander function beyond the SNX17-mediated regulation of cell surface proteome.

Indexed as

Albinism, Oculocutaneousrab GTP-Binding ProteinsSorting NexinsCell MembraneHEK293 CellsHumansMelanocytesMelanosomesMutationProtein BindingProtein Transportrab GTP-Binding ProteinsSorting Nexins

Identifiers

PMID41038817
PMCPMC12491506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.